| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2583327 | Environmental Toxicology and Pharmacology | 2013 | 9 Pages |
The therapeutic potential of coenzyme Q10 was investigated in rats with hepatocellular carcinoma induced by trichloroacetic acid (0.5 g/kg/day, p.o., for five days). Coenzyme Q10 treatment (0.4 mg/kg/day, i.p.) was applied for four weeks following trichloroacetic acid administration. Coenzyme Q10 significantly suppressed lipid peroxidation, prevented the depletion of reduced glutathione and superoxide dismutase activity, and decreased the elevations of tumor necrosis factor-α and nitric oxide in liver tissue of rats with hepatocellular carcinoma. Also, the histopathological dysplastic changes induced by trichloroacetic acid in liver tissue were ameliorated by coenzyme Q10. Immunohistochemical analysis revealed that coenzyme Q10 significantly decreased the expression of hepPar-1, alpha-fetoprotein, inducible nitric oxide synthase, cyclooxygenase-2 and nuclear factor-κB in liver tissue of rats with hepatocellular carcinoma. It was concluded that coenzyme Q10 may represent a potential therapeutic option for liver carcinogenesis.
► Hepatocellular carcinoma is associated with oxidative stress and inflammation of liver tissue. ► Coenzyme Q10 has prominent antioxidant and anti-inflammatory properties. ► Coenzyme Q10 attenuated experimentally-induced hepatocellular carcinoma in rats through its antioxidant and anti-inflammatory effects.
